BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8737920)

  • 1. Metabolism of benzocaine during percutaneous absorption in the hairless guinea pig: acetylbenzocaine formation and activity.
    Kraeling ME; Lipicky RJ; Bronaugh RL
    Skin Pharmacol; 1996; 9(3):221-30. PubMed ID: 8737920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro skin absorption and metabolism of benzoic acid, p-aminobenzoic acid, and benzocaine in the hairless guinea pig.
    Nathan D; Sakr A; Lichtin JL; Bronaugh RL
    Pharm Res; 1990 Nov; 7(11):1147-51. PubMed ID: 2293213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioadhesive films containing benzocaine: correlation between in vitro permeation and in vivo local anesthetic effect.
    de Araujo DR; Padula C; Cereda CM; Tófoli GR; Brito RB; de Paula E; Nicoli S; Santi P
    Pharm Res; 2010 Aug; 27(8):1677-86. PubMed ID: 20422264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of bioadhesive benzocaine gels for enhanced local anesthetic effects.
    Shin SC; Lee JW; Yang KH; Lee CH
    Int J Pharm; 2003 Jul; 260(1):77-81. PubMed ID: 12818812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity.
    Storm JE; Collier SW; Stewart RF; Bronaugh RL
    Fundam Appl Toxicol; 1990 Jul; 15(1):132-41. PubMed ID: 2373294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and metabolic studies on amino acid benzocaine derivatives.
    Słojkowska Z; Misterek K; Klimecka H; Pachecka J
    Pol J Pharmacol Pharm; 1981; 33(1):99-106. PubMed ID: 7255285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous absorption/metabolism of phenanthrene in the hairless guinea pig: comparison of in vitro and in vivo results.
    Ng KM; Chu I; Bronaugh RL; Franklin CA; Somers DA
    Fundam Appl Toxicol; 1991 Apr; 16(3):517-24. PubMed ID: 1855623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of azo dyes during in vitro percutaneous absorption.
    Collier SW; Storm JE; Bronaugh RL
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):73-9. PubMed ID: 8430426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of skin binding on percutaneous transport of benzocaine from aqueous suspensions and solutions.
    Dalvi UG; Zatz JL
    J Pharm Sci; 1982 Jul; 71(7):824-6. PubMed ID: 7120074
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of metabolism in skin on dosimetry after topical exposure.
    Bronaugh RL; Collier SW; Macpherson SE; Kraeling ME
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):71-4. PubMed ID: 7737045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for percutaneous absorption.
    Jung EC; Maibach HI
    J Appl Toxicol; 2015 Jan; 35(1):1-10. PubMed ID: 25345378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of an alpha hydroxy acid (glycolic acid) on hairless guinea pig skin permeability.
    Hood HL; Kraeling ME; Robl MG; Bronaugh RL
    Food Chem Toxicol; 1999 Nov; 37(11):1105-11. PubMed ID: 10566882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common local anesthetic receptor for benzocaine and etidocaine in voltage-gated mu1 Na+ channels.
    Wang GK; Quan C; Wang S
    Pflugers Arch; 1998 Jan; 435(2):293-302. PubMed ID: 9382945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzocaine diffusion from polyethylene glycol through human stratum corneum.
    Belmonte AA; Tsai W
    J Pharm Sci; 1978 Apr; 67(4):517-20. PubMed ID: 641761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine.
    Üstündağ Okur N; Çağlar EŞ; Arpa MD; Karasulu HY
    Pharm Dev Technol; 2017 Jun; 22(4):500-510. PubMed ID: 26738443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption.
    Boehnlein J; Sakr A; Lichtin JL; Bronaugh RL
    Pharm Res; 1994 Aug; 11(8):1155-9. PubMed ID: 7971717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the suitability of benzocaine as a positive control skin sensitizer.
    Basketter DA; Scholes EW; Wahlkvist H; Montelius J
    Contact Dermatitis; 1995 Jul; 33(1):28-32. PubMed ID: 7493458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro dermal absorption of benzo[a]pyrene in rat, guinea pig, human and tissue-cultured skin.
    Moody RP; Nadeau B; Chu I
    J Dermatol Sci; 1995 Jan; 9(1):48-58. PubMed ID: 7727354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers.
    Puglia C; Sarpietro MG; Bonina F; Castelli F; Zammataro M; Chiechio S
    J Pharm Sci; 2011 May; 100(5):1892-9. PubMed ID: 21374621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use-dependent inhibition of Na+ currents by benzocaine homologs.
    Quan C; Mok WM; Wang GK
    Biophys J; 1996 Jan; 70(1):194-201. PubMed ID: 8770198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.